Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
0.430
-0.050 (-10.34%)
At close: Jan 14, 2025, 4:00 PM
0.449
+0.019 (4.42%)
After-hours: Jan 14, 2025, 6:10 PM EST
Klotho Neurosciences Market Cap
Klotho Neurosciences has a market cap or net worth of $9.14 million as of January 14, 2025. Its market cap has decreased by -90.25% in one year.
Market Cap
9.14M
Enterprise Value
9.09M
1-Year Change
-90.25%
Ranking
Category
Stock Price
0.43
Market Cap Chart
Since April 29, 2022, Klotho Neurosciences's market cap has decreased from $127.33M to $9.14M, a decrease of -92.82%. That is a compound annual growth rate of -62.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2025 | 10.20M | -1.11% |
| Dec 31, 2024 | 10.31M | -89.05% |
| Dec 22, 2023 | 94.18M | -37.22% |
| Dec 20, 2022 | 150.02M | 17.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.74B |
| UnitedHealth Group | 500.40B |
| Novo Nordisk | 362.64B |
| Johnson & Johnson | 348.50B |
| AbbVie | 310.22B |
| Merck & Co. | 252.08B |
| Thermo Fisher Scientific | 213.05B |
| AstraZeneca | 200.99B |